First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Eur J Clin Microbiol Infect Dis. 2020 Oct;39(10):1989-1991. doi: 10.1007/s10096-020-03917-5. Epub 2020 May 2.

Abstract

Tsukamurella spp. are gram-positive rods that can be isolated from the environment in soil and moist areas. In rare instances, they are known to cause infections in immunocompromised hosts. We present the first reported case of Tsukamurella endocarditis in an immunocompromised patient who was successfully treated with a 6-week course of imipenem and trimethoprim-sulfamethoxazole.

Keywords: Bacteremia; Endocarditis; Immunocompromised; Tsukamurella; Tsukamurella pulmonis.

Publication types

  • Case Reports

MeSH terms

  • Actinobacteria / genetics
  • Actinobacteria / isolation & purification*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Diagnosis, Differential
  • Endocarditis, Bacterial / diagnosis*
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / microbiology
  • Female
  • Humans
  • Imipenem / administration & dosage
  • Imipenem / therapeutic use
  • Immunocompromised Host*
  • Lung Neoplasms / drug therapy
  • Middle Aged
  • Small Cell Lung Carcinoma / drug therapy
  • Trimethoprim, Sulfamethoxazole Drug Combination / administration & dosage
  • Trimethoprim, Sulfamethoxazole Drug Combination / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Imipenem
  • Trimethoprim, Sulfamethoxazole Drug Combination

Supplementary concepts

  • Tsukamurella pulmonis